Synaptiq, a Romanian startup from Cluj-Napoca, closes a 250.000 euros funding round with the participation of GapMinder VC, Cleverage VC and two angel investors.
Synaptiq increases the performance of healthcare services by developing AI-based solutions for delineating tumors and organs at risk.
The startup is working on the development of Mediq platform, which reduces the analysis time of medical images in radiotherapy cancer treatment procedures.
The Mediq software uses AI to delineate cancerous tumors in CT and MRI images in a much shorter time with greater accuracy and objectivity.
This means doctors will no longer have to spend hours to perform organ delineation and can focus on treatment, planning, and finding the best approach to save the patient’s life.
The Mediq platform uses Deep Learning to support rapid diagnosis and integrates workflow into telemedicine applications to streamline communication between healthcare professionals.
As a result, clinics will be able to create a treatment plan for a much larger number of patients, as the implementation time will be much reduced.
In early 2022, Synaptiq will launch the beta version of the Mediq product and is preparing to complete the European accreditation process.